Skip to content

Clinical trials

Phase 2 Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2 Country / region: United States Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20044
20052
20068
20078
20088
20096
20105
20114
20126
20131
20145
201513
20163
20175
20183
20198
20204
20212
20224
20234
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Terminated29
Recruiting7
Unknown status4
Withdrawn4
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan9
National Eye Institute (NEI)6
Novartis Pharmaceuticals6
GlaxoSmithKline5
Snyder, Robert W., M.D., Ph.D., P.C.4
Genaera Corporation3
Genentech, Inc.3
Manhattan Eye, Ear & Throat Hospital3
Ophthotech Corporation3
Regeneron Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration116
Geographic Atrophy25
Choroidal Neovascularization20
Retinal Degeneration8
Eye Diseases7
Retinal Diseases7
Wet Macular Degeneration6
Macular Edema4
Blindness3
Diabetic Retinopathy3

Trials

Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.